Lexpos News

/Lexpos News/

Just over a week left to complete the 2026 mandatory workforce survey

Pharmacy owners have just over a week left to complete the 2026 workforce survey, which is a mandatory requirement for all pharmacy owners. The data will be collected via an online survey which can be accessed by logging into the NHSBSA’s Manage Your Service (MYS) portal. The survey will close at 11.59pm on Saturday 14th November 2026. [...]

The post Just over a week left to complete the 2026 mandatory workforce survey appeared first on Community Pharmacy England.

By |November 6th, 2026|Lexpos News, Workforce, Workforce survey|Comments Off on Just over a week left to complete the 2026 mandatory workforce survey

MHRA Class 3 Medicines Recall: Tropicamide 1% Eye Drops, solution in single dose containers 20 x 0.5ml (Aspire Pharma Limited)

MHRA Class 3 Medicines Recall: Tropicamide 1% Eye Drops, solution in single dose containers 20 x 0.5ml (Aspire Pharma Limited) Drug Alert Number: EL(26)A/47 Date issued: 4 November 2026 Aspire Pharma Ltd is recalling specific batches of Tropicamide 1% Eye Drops, solution in single dose containers 0.5ml x 20, due to them being labelled with [...]

The post MHRA Class 3 Medicines Recall: Tropicamide 1% Eye Drops, solution in single dose containers 20 x 0.5ml (Aspire Pharma Limited) appeared first on Community Pharmacy England.

By |November 5th, 2026|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Tropicamide 1% Eye Drops, solution in single dose containers 20 x 0.5ml (Aspire Pharma Limited)

MHRA Class 4 Medicines Defect Notification: Co-Amoxiclav powder for oral suspension 250/62.5 mg/ml (Sandoz Limited)

MHRA Class 4 Medicines Defect Notification: Co-Amoxiclav powder for oral suspension 250/62.5 mg/ml (Sandoz Limited) Drug alert number: EL(26)A/46 Date issued: 05 November 2026 Sandoz Limited have informed the MHRA of errors in the dosing table in the Summary of Product Characteristics (SmPC) for Co-amoxiclav 250/62.5 mg/5 ml Powder for Oral Suspension. DMRC reference number: DMRC- [...]

The post MHRA Class 4 Medicines Defect Notification: Co-Amoxiclav powder for oral suspension 250/62.5 mg/ml (Sandoz Limited) appeared first on Community Pharmacy England.

By |November 5th, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Co-Amoxiclav powder for oral suspension 250/62.5 mg/ml (Sandoz Limited)

October 2026 Price Concessions Final Update (Improved Prices)

The Department of Health and Social Care (DHSC) has today (04/11/2026) confirmed the following list of price concessions for October 2026. This list for October 2026 includes 16 improved prices following representations made by Community Pharmacy England on behalf of community pharmacy owners. Drug Pack size Price concession Flucloxacillin 125mg/5ml oral solution 100 £8.71 (previously [...]

The post October 2026 Price Concessions Final Update (Improved Prices) appeared first on Community Pharmacy England.

By |November 4th, 2026|Lexpos News|Comments Off on October 2026 Price Concessions Final Update (Improved Prices)

Rolled over price concessions for November 2026

The following price concessions granted in October 2026 have rolled over to November 2026: Drug Pack size Price concession Alfacalcidol 250nanogram capsules 30 £2.45 Desmopressin 120microgram sublingual tablets sugar free 30 £13.68 Gliclazide 40mg tablets 28 £1.30 Glimepiride 1mg tablets 30 £1.21 Glimepiride 2mg tablets 30 £2.17 Glimepiride 3mg tablets 30 £3.25 Glimepiride 4mg tablets [...]

The post Rolled over price concessions for November 2026 appeared first on Community Pharmacy England.

By |November 4th, 2026|Lexpos News|Comments Off on Rolled over price concessions for November 2026